Actions of ferulic acid and vitamin e on prevention of hypercholesterolemia and atherogenic lesion formation in apolipoprotein e-deficient mice

Journal of Medicinal Food

Volumn 12, Issue 5, 2009, Pages 996-1003

  Kwon, Eun Young ^a   Cho, Yun Young ^a   Do, Gyeong Min ^a   Kim, Hye Jin ^b   Jeon, Seon Min ^a   Park, Yong Bok ^c   Lee, Mi Kyung ^d   Min, Tae Sun ^e   Choi, Myung Sook ^a  

^a Department of Food Science and Nutrition ^*  (South Korea)

^b CJ Corporation   (South Korea)

^c Kyungpook National University   (South Korea)

^d Sunchon National University   (South Korea)

^e National Research Foundation of Korea   (South Korea)

Author keywords

Atherogenesis; Ferulic acid; Hypercholesterolemia; Phenolic compound; Vitamin E

Indexed keywords

ACYL COENZYME A; ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CATALASE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; FERULIC ACID; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ACYL COENZYME A; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; COUMARIC ACIDS; DIET; DRUG THERAPY, COMBINATION; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHYTOTHERAPY; PLANT EXTRACTS; STEROL O-ACYLTRANSFERASE; THIOBARBITURATES; VITAMIN E;

MUS;

EID: 70350497340     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0105     Document Type: Article

References (35)

1. Aviram M: Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
2. Berliner JA, Navab M, Fogelman AM, et al.: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488-2496.
3. Whitman SC: A practical approach to using mice in atherosclerosis research. Clin Biochem Rev 2004;25:81-93.
4. Munteanu A, Zingg JM, Azzi A: Anti-atherosclerotic effects of vitamin E-myth or reality? J Cell Mol Med 2004;8:59-76.
5. Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, Vessby B: Effect of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000;35:427-435.
6. Upston JM, Kritharides L, Stocker R: The role of vitamin E in atherosclerosis. Prog Lipid Res 2003;42:405-422.
7. Adom KK, Sorrells ME, Liu RH: Phytochemical profiles and antioxidant activity of wheat varieties. J Agric Food Chem 2003;51:7825-7834.
8. Kanaski J, Aksenova M, Stoyanova A, Butterfield DA: Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure activity studies. J Nutr Biochem 2002;13:273-281.
9. Kim HK, Jeong TS, Lee MK, Park YB, Choi MS: Lipid lowering efficacy of hesperidine metabolites in high-cholesterol fed rats. Clin Chim Acta 2003;327:129-137.
10. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL: ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994;14:605-616.
11. McCord JM, Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-6055.
12. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
13. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
14. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-358.
15. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
16. Aebi H: Catalase. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed.). Academic Press, New York, 1974, pp. 673-784.
17. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
18. Mackness MI, Harty D, Bhatnagar D, et al.: Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991;86:193-199.
19. Erickson SK, Shrewsbury, MA, Brooks C, Meyer DJ: Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J Lipid Res 1980;21: 930-941.
20. Gillies PJ, Rathgeb KA, Perri MA, Robinson CS: Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool. Exp Mol Pathol 1986;44:329-339.
21. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK: Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003;112:1342-1350.
22. Zhang SH, Reddick RL, Piedrahita, JA, Maeda N: Spontaneous hypercholesterolemia and artherial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
23. Maor I, Hayek T, Coleman R, Aviram M: Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997;17:2995-3005.
24. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ: Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;94:153-159.
25. Yogeeta SK, Hanumantra RB, Gnanapragasam A, Senthilkumar S, Subhashini R, Devaki T: Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Basic Clin Pharmacol Toxicol 2006;98:467-472.
26. Hiramatsu K, Tani T, Kimura Y, Izumi S, Nakane PK: Effect of gamma-oryzanol on atheroma formation in hypercholesterolemic rabbits. Tokai J Exp Clin Med 1990;15:299-305.
27. Anuurad E, Boffa MB, Koschinsky ML, Berglund L: Lipoprotein( a): a unique risk factor for cardiovascular disease. Clin Lab Med 2006;26:751-772.
28. Carr TP, Parks JS, Rudel LL: Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 1992;12:1274-1283.
29. Jeon SM, Park YB, Kwon OS, et al.: Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol. J Biochem Mol Toxicol 2005;19:336-346.
30. Akkus I, Sag¢lam NI, Cag¢layan O, Vural H, Kalak S, Sag¢lam M: Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography. Clin Chim Acta 1996;244:173-180.
31. Mackness M, Boullier A, Hennuyer N, et al.: Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun 2000;269:232-236.
32. Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S: Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol (Oxf) 2004;61:515-521.
33. Górnicka G, Bełtowski J, Wójcicka G, Jamroz A: [Serum paraoxonase activity, total antioxidant potential and lipid peroxidation products in children with bronchial asthma exacerbation]. Wiad Lek 2002;55:257-263.
34. Haron D: The aging process: major risk factor for disease and death. Proc Natl Acad Sci U S A 1991;88:5360-5363.
35. Thomas SR, Leichtweis SB, Pettersson K, et al.: Dietary cosupplementation with vitamin E and coenzyme Q10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 2001;21:585-593.